Methamphetamine, mitochondria, and neurodegeneration
Methamphetamine, mitochondria, and neurodegeneration
批准号:
10382336
负责人:
Steven Michael Graves
金额:
$38.68万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-04-15 至 2026-01-31
关键词:
ATP Synthesis PathwayAbstinenceAchievementAntioxidantsAxonBackBehavioralBiosensorBrainBuffersChronicDangerousnessDataDependenceDopamineDorsalHumanImmunohistochemistryImpaired cognitionImpairmentLaser Scanning MicroscopyMetabolismMethamphetamineMitochondriaMusNerve DegenerationNeuronsNeurotransmittersNorepinephrinePatternPharmacologyPilot ProjectsProteinsResistanceRoleSerotoninSliceStressSubstantia nigra structureTestingVentral Tegmental AreaVesicleVulnerable Populationscalbindinconditioned feardensityexperimental studygenetic approachgenetic manipulationlocus ceruleus structuremethamphetamine abusemonoamineneuron lossneuronal cell bodynovelobject recognitionpars compactapreventpsychostimulanttwo-photonvesicular monoamine transporter 2
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT
Methamphetamine (meth) is an addictive psychostimulant. Our pilot studies show that chronic meth resulted in
degeneration of substantia nigra pars compacta (SNc) dopamine (DA) and locus coeruleus (LC) norepinephrine
(NE) but not ventral tegmental area (VTA) DA or dorsal raphe (DR) serotonin (5-HT) neurons in mice. DA, NE,
and 5-HT are monoamine neurotransmitters synthesized and packaged into vesicles in axonal compartments.
Meth increases cytosolic monoamines and MAO-dependent mitochondrial stress in SNc axons but not the soma.
Pilot studies show that MAO inhibition prevented meth-induced SNc degeneration. These data suggest that
degeneration is driven by MAO-dependent axonal mitochondrial stress. However, pilot data show meth also
increased LC, VTA, and DR axonal mitochondrial stress yet chronic meth induced SNc and LC but not VTA or
DR degeneration. We found L-type Ca2+ channel (LCC)-dependent mitochondrial stress in SNc but not VTA
axons. We propose a `two-hit' hypothesis wherein both MAO- and LCC-dependent axonal mitochondrial stress
are required for degeneration. The degeneration `trigger' is meth-induced MAO-dependent axonal mitochondrial
stress and vulnerability is a consequence of axonal LCC-dependent mitochondrial stress. Since MAO- and LCC-
dependent stress converge in axons, we propose that axonal loss precedes somatic loss in a `dying-back' pattern
of degeneration. Pilot data indicate that SNc axonal mitochondrial stress was increased during abstinence. We
hypothesize this stress is MAO-dependent and contributes to degeneration during abstinence. Lastly, meth-
induced degeneration is expected to impair novel object recognition and fear conditioning which are dependent
on DA and NE, respectively. Hypotheses will be tested using two-photon laser scanning microscopy in brain
slices, genetically encoded biosensors, pharmacological and genetic manipulation of MAO/LCCs, and
immunohistochemistry. Aim 1: Determine mechanisms of mitochondrial stress in monoaminergic axons,
consequences of chronic meth on mitochondria, and whether mitochondrial stress continues during
abstinence. We hypothesize that SNc, VTA, LC, and DR axons all have meth-induced MAO-dependent
mitochondrial stress whereas SNc and LC but not VTA or DR axons will have LCC-induced mitochondrial stress.
We also hypothesize that axonal stress will remain elevated throughout abstinence from chronic meth and will
be MAO-dependent. Aim 2: Determine the roles of MAO and LCCs in chronic meth-induced degeneration
and behavioral consequences. We hypothesize that pharmacologically inhibiting or genetically deleting MAO
or LCCs will prevent chronic meth-induced degeneration of vulnerable (SNc and LC) neurons and deleting the
Ca2+ buffering protein calbindin from resistant (VTA and DR) neurons will render them vulnerable to
degeneration. We further hypothesize that degeneration will be progressive throughout abstinence and MAO-
dependent. Lastly, we hypothesize that SNc and LC degeneration will result in cognitive impairments.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Methamphetamine, mitochondria, and neurodegeneration
-
批准号:10554338
-
项目类别:
-
资助金额:$38.68万
-
财政年份:2021
-
负责人:Steven Michael Graves
-
依托单位:
Methamphetamine, mitochondria, and neurodegeneration
-
批准号:10209204
-
项目类别:
-
资助金额:$36.12万
-
财政年份:2021
-
负责人:Steven Michael Graves
-
依托单位:
Chronic alcohol-induced mitochondrial oxidant stress and Alzheimer's related pathogenesis
-
批准号:10436351
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2020
-
负责人:Steven Michael Graves
-
依托单位:
Chronic alcohol-induced mitochondrial oxidant stress and Alzheimer's related pathogenesis
-
批准号:10659030
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2020
-
负责人:Steven Michael Graves
-
依托单位:
Chronic alcohol-induced mitochondrial oxidant stress and Alzheimer's related pathogenesis
-
批准号:10264166
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2020
-
负责人:Steven Michael Graves
-
依托单位:
Methamphetamine and Parkinson's disease: converging mechanisms of pathogenesis
-
批准号:9033364
-
项目类别:
-
资助金额:$13.69万
-
财政年份:2016
-
负责人:Steven Michael Graves
-
依托单位:
Methamphetamine and Parkinson's disease: converging mechanisms of pathogenesis
-
批准号:9258419
-
项目类别:
-
资助金额:$13.69万
-
财政年份:2016
-
负责人:Steven Michael Graves
-
依托单位:
L-DOPA-induced dyskinesias and dysregulation of striatopallidal neurons
-
批准号:8758664
-
项目类别:
-
资助金额:$2.64万
-
财政年份:2013
-
负责人:Steven Michael Graves
-
依托单位:
L-DOPA-induced dyskinesias and dysregulation of striatopallidal neurons
-
批准号:8596683
-
项目类别:
-
资助金额:$4.92万
-
财政年份:2013
-
负责人:Steven Michael Graves
-
依托单位:
5HT receptors, neuronal plasticity, and methamphetamine-induced place perference.
-
批准号:7777356
-
项目类别:
-
资助金额:$3.58万
-
财政年份:2009
-
负责人:Steven Michael Graves
-
依托单位:
5HT receptors, neuronal plasticity, and methamphetamine-induced place perference.
-
批准号:8012804
-
项目类别:
-
资助金额:$3.62万
-
财政年份:2009
-
负责人:Steven Michael Graves
-
依托单位:
5HT receptors, neuronal plasticity, and methamphetamine-induced place perference.
-
批准号:7614668
-
项目类别:
-
资助金额:$3.56万
-
财政年份:2009
-
负责人:Steven Michael Graves
-
依托单位:
海外基金